__NUXT_JSONP__("/drugs/JNK_Inhibitor_CC-401", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A second generation ATP-competitive anthrapyrazolone c-Jun N terminal kinase (JNK) inhibitor with potential antineoplastic activity. Based on the chemistry of SP600125, another anthrapyrazolone inhibitor of JNK, CC-401 competitively binds the ATP binding site of JNK, resulting in inhibition of the phosphorylation of the N-terminal activation domain of transcription factor c-Jun; decreased transcription activity of c-Jun; and a variety of cellular effects including decreased cellular proliferation.",fdaUniiCode:"NOE38VQA1W",identifier:"C49095",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C2149"],synonyms:["CC-401",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FJNK_Inhibitor_CC-401",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","JNK_Inhibitor_CC-401","JNK Inhibitor CC-401","2021-10-30T13:40:23.823Z")));